Suwon, South Korea

Kwi Hyon Seo

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Yungjin Pharmaceutical Co., Ltd.. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwi Hyon Seo. Retrieved from https://idiyas.com/inventor/kwi-hyon-seo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 12.5

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kwi Hyon Seo: Innovator in Pharmaceutical Chemistry

Introduction

Kwi Hyon Seo is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Seo has established himself as a key figure in the development of new chemical compounds.

Latest Patents

Seo's latest patents include groundbreaking work on heterocycle-fused thiazole derivatives and 4-amino-3-acylnaphthyridine derivatives. These inventions showcase his expertise in creating novel compounds that have potential applications in various therapeutic areas.

Career Highlights

Throughout his career, Kwi Hyon Seo has worked with prominent companies such as Yungjin Pharmaceutical Co., Ltd. His experience in the pharmaceutical industry has allowed him to apply his innovative ideas to real-world challenges, contributing to advancements in drug development.

Collaborations

Seo has collaborated with talented individuals in his field, including Young Hun Kim and Kae Jong Chung. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the quality of their work.

Conclusion

Kwi Hyon Seo is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing the field. His work continues to inspire future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…